secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0000950170-25-040230
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta stockholders approve 800k-share increase to 2019 equity plan; re-elect directors
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2019 Equity Incentive Plan, adding 800,000 shares (11,435,985 for, 4,085,303 against).
- Mark G. Foletta and Lesley Russell re-elected as Class III directors until 2028 annual meeting.
- Advisory vote on executive compensation passed (14,516,861 for, 1,039,888 against); frequency set to annual.
- PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2025 (17,740,127 for, 72,357 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000095017025040230/0000950170-25-040230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000095017025040230/enta-20250313.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-040230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer